login
login

Europe Daily Bulletin No. 12774

24 August 2021
EU RESPONSE TO COVID-19 / Health
Seven potential treatments for Covid-19 are now under review by EMA
Brussels, 23/08/2021 (Agence Europe)

The European Medicines Agency (EMA) announced on Monday 16 August that it had started a rolling review of a seventh potential treatment for Covid-19 - RoActemra (tocilizumab), an anti-inflammatory drug authorised in the European Union since 2009.

In a statement, the EMA said that if the “rolling review” is successful, the treatment could be extended to adult in-patients with severe Covid-19, “who are already receiving treatment with corticosteroids and require extra oxygen or...

Contents

BEACONS
EXTERNAL ACTION
EU RESPONSE TO COVID-19
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS